Eton Pharmaceuticals Inc. (ETON) Tops Q1 EPS by 22c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q1 EPS of $0.10, $0.22 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $5.3 million versus the consensus estimate of $4.8 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• Stifel Starts GlobalFoundries Inc. (GFS) at Buy, Top Pick
• MongoDB stock tumbles despite earnings beat on profit-taking